Diabetes Care for Breast Cancer Patients

Description

The goal of this study is to find a new way to make diabetes care better for patients with breast cancer and diabetes who are currently receiving cancer treatment. We will have two groups, the researchers will decide who is in which group. One group will be working with a nurse who is trained in diabetes care while the other does not. This will allow the investigators to see if having a trained nurse as part of the care team can help improve the care the patients receive.

Conditions

Breast Cancer, PreDiabetes, Type 2 Diabetes

Study Overview

Study Details

Study overview

The goal of this study is to find a new way to make diabetes care better for patients with breast cancer and diabetes who are currently receiving cancer treatment. We will have two groups, the researchers will decide who is in which group. One group will be working with a nurse who is trained in diabetes care while the other does not. This will allow the investigators to see if having a trained nurse as part of the care team can help improve the care the patients receive.

Optimizing Delivery of Diabetes Management During Breast Cancer Care

Diabetes Care for Breast Cancer Patients

Condition
Breast Cancer
Intervention / Treatment

-

Contacts and Locations

Brooklyn

NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, United States, 11215

Flushing

New York-Presbyterian Queens, Flushing, New York, United States, 11355

New York

Weill Cornell Medicine, New York, New York, United States, 10021

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Newly diagnosed invasive cancer
  • * Plan to receive neo-adjuvant or adjuvant chemotherapy, targeted therapy, hormonal therapy, or radiation at Weill Cornell Medicine (WCM)
  • * Age 18+ years
  • * Pre-diabetes OR type 2 diabetes. Treatment with antidiabetic medication OR
  • * HbA1c greater than or equal to 5.7 OR
  • * Random glucose greater than or equal to OR
  • * Fasting blood glucose greater than or equal to 100
  • * Patients receiving hospice care
  • * Type 1 diabetes

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Weill Medical College of Cornell University,

Laura C Pinheiro, PhD, MPH, PRINCIPAL_INVESTIGATOR, Assistant Professor of Health Services Research in Medicine

Study Record Dates

2026-12